Symbol: |
LDOC1L
|
Description: |
leucine zipper, down-regulated in cancer 1-like [Source:HGNC Symbol;Acc:13343]
|
Location: |
Chr22:44888452-44894178[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:245
Gene |
Compound |
Gen_sig |
Exp_pattern |
LDOC1L |
Camptothecin hemisuccinate sodium salt |
0.028 |
Down |
LDOC1L |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.008 |
Down |
LDOC1L |
2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- |
0.012 |
Up |
LDOC1L |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.035 |
Down |
LDOC1L |
NSC 62349 |
0.01 |
Down |
LDOC1L |
NSC 6246 |
0.013 |
Up |
LDOC1L |
Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(2-methoxy- phenyl)methylene]-, hydrochloride |
0.012 |
Up |
LDOC1L |
Benzo[g]pteridine-2,4-dione, 8-chloro-10-(4-chlorophenyl)- 3-methyl- |
0.026 |
Up |
LDOC1L |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.013 |
Down |
LDOC1L |
9-AMINO-20-CAMPTOTHECIN |
0.013 |
Down |
LDOC1L |
cis-Dichlorobis(4-methoxyphenethylamine)platinum(II) |
0.012 |
Up |
LDOC1L |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.029 |
Down |
LDOC1L |
NSC 639211 |
0.003 |
Up |
LDOC1L |
3,8,13,18-Pentaazapentacosane pentahydrochloride |
0.007 |
Up |
LDOC1L |
Chlorodestruxin |
0.017 |
Up |
Expression pattern: Sensitivity / Resistance
Total:17 Current:4
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:100
Total:7 Current:1
[First] [Prev]  Next Last 
|
miRNA:
~ Export ~
|
Records:2
Gene |
Gen_transcript |
miRNA |
miR_location |
LDOC1L |
ENST00000341255 |
hsa-mir-329 |
Chr14:101493171-101493192[+] |
LDOC1L |
ENST00000341255 |
hsa-mir-329 |
Chr14:101493488-101493509[+] |
Total:1 Current:1
[First] [Prev] [Next] [Last]
|